Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma

Abstract

Melanoma incidence is growing at a faster rate than any other human malignancy. Wild-type (wt) p53 is important in both G1 and G2 cell cycle arrest, and cyclin D1 (CD1) is necessary for G1→S progression in melanoma cells. We reported that an adenoviral vector containing wt p53 significantly reduced [3H]thymidine uptake in melanoma cells containing mutant but not wt p53. Subsequently we showed that CD1 decreased melanoma proliferation and increased apoptosis. We now extend these findings by evaluating the effect on preformed melanomas of (1) intratumoral therapy with wt p53 alone, (2) wt p53 in combination with antisense (AS) CD1, both short (≤14 days) and longer term, and (3) doubling the dose or repeat doses of wt p53 or AS CD1. Two melanoma cells lines that metastasize in SCID mice (451 and 1205) were used, one containing a p53 mutation (451) and the other a normal p53 gene sequence (1205). Compared to injection with a control adenoviral vector containing β-galactosidase (LacZ), intratumoral injection of wt p53 slowed the growth of tumors formed from 451 cells. Using 5×108 plaque forming units as our standard intratumoral dose, neither doubling the dose of LacZ, p53 or AS CD1, nor repeat doses of the vectors, was as effective as combined therapy with wt p53+AS CD1, which resulted in the shrinkage of all tumors treated and 4/7 (57%) tumors vanished. No tumors treated with wt p53 or AS CD1 alone vanished. Wt p53+AS CD1 treatment resulted in significantly more cells undergoing apoptosis compared to either therapy alone. In summary, combining the separately effective treatment vectors p53 and AS CD1 led to an enhanced growth-suppressive and apoptotic effect, supporting a role for combination gene therapy to treat human malignant melanoma.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. ACS. Cancer Facts and Figures 2002 Atlanta: American Cancer Society 2002

  2. Brash DE, Rudolph JA, Simon JA et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma Proc Natl Acad Sci USA 1991 88: 10124–10128

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lee JY, Dong SM, Shin MS et al. Genetic alterations of p16INK4a and p53 genes in sporadic dysplastic nevus Biochem Biophys Res Commun 1997 237: 667–672

    Article  CAS  PubMed  Google Scholar 

  4. Weiss J, Heine M, Arden KC et al. Mutation and expression of TP53 in malignant melanomas Recent Results Cancer Res 1995 139: 137–154

    Article  CAS  PubMed  Google Scholar 

  5. Hartmann A, Blaszyk H, Cunningham JS et al. Overexpression and mutations of p53 in metastatic malignant melanomas Int J Cancer 1996 67: 313–317

    Article  CAS  PubMed  Google Scholar 

  6. Ley RD, Applegate LA, Padilla RS et al. Ultraviolet radiation-induced malignant melanoma in Monodelphia domestica Photochem Photobiol 1989 50: 1–5

    Article  CAS  PubMed  Google Scholar 

  7. Romerdahl CA, Stephens LC, Bucana C et al. The role of ultraviolet radiation in the induction of melanocytic skin tumors in inbred mice Cancer Commun 1989 1: 209–216

    CAS  PubMed  Google Scholar 

  8. Berking C, Takemoto R, Satyamoorthy K et al. Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin Am J Pathol 2001 158: 943–953

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Helin K, Harlow E . The retinoblastoma protein as a transcriptional repressor Trends Cell Biol 1992 3: 43–46

    Article  Google Scholar 

  10. Deng C, Zhang P, Harper JW et al. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control Cell 1995 82: 675–684

    Article  CAS  PubMed  Google Scholar 

  11. Evdokiou A, Raggatt LJ, Atkins GJ et al. Calcitonin receptor-mediated growth suppression of HEK-293 cells is accompanied by induction of p21WAF1/CIP1 and G2/M arrest [In Process Citation] Mol Endocrinol 1999 13: 1738–1750

    Article  CAS  PubMed  Google Scholar 

  12. Zhan Q, Antinore MJ, Wang XW et al. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45 Oncogene 1999 18: 2892–2900

    Article  CAS  PubMed  Google Scholar 

  13. Hinds PW, Dowdy SF, Eaton EN et al. Function of a human cyclin gene as an oncogene Proc Natl Acad Sci USA 1994 91: 709–713

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Matsushime HD, Quelle E, Shurtleff SA et al. D-type cyclin-dependent kinase activity in mammalian cells Mol Cell Biol 1994 14: 2066–2076

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Rieber MS, Rieber M . Suppression of cyclin D1 but not cdk4 or cyclin A with induction of melanoma terminal differentiation Biochem Biophys Res Commun 1995 216: 422–427

    Article  CAS  PubMed  Google Scholar 

  16. Bartkova J, Lukas J, Guldberg P et al. The p16-cyclin D1/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis Cancer Res 1996 56: 5475–5483

    CAS  PubMed  Google Scholar 

  17. Satyamoorthy K, Chehab NH, Waterman MJ et al. Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells Cell Growth Differ 2000 11: 467–474

    CAS  PubMed  Google Scholar 

  18. Sauter ER, Nesbit M, Litwin S et al. Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas Cancer Res 1999 59: 4876–4881

    CAS  PubMed  Google Scholar 

  19. Sauter ER, Yeo UC, van Stemm A et al. Cyclin D1 is a candidate oncogene in cutaneous melanoma Cancer Res 2002 3200–3206

  20. Jenq W, Wu SJ, Kefalides NA . Expression of the alpha 2-subunit of laminin correlates with increased cell adhesion and metastatic propensity Differentiation 1994 58: 29–36

    Article  CAS  PubMed  Google Scholar 

  21. Herlyn D, Iliopoulos D, Jensen PJ et al. In vitro properties of human melanoma cells metastatic in nude mice Cancer Res 1990 50: 2296–2302

    CAS  PubMed  Google Scholar 

  22. Iliopoulos D, Ernst C, Steplewski Z et al. Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides J Natl Cancer Inst 1989 81: 440–444

    Article  CAS  PubMed  Google Scholar 

  23. Graham FL, Smiley J, Russell WC et al. Characteristics of a human cell line transformed by DNA from human adenovirus type 5 J Gen Virol 1977 36: 59–74

    Article  CAS  PubMed  Google Scholar 

  24. El-Deiry WS, Tokino T, Velculescu VE et al. WAF1, a potential mediator of p53 tumor suppression Cell 1993 75: 817–825

    Article  CAS  PubMed  Google Scholar 

  25. Wilkinson GWG, Akrigg A . Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector Nucleic Acids Res 1992 20: 2233–2239

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Ranheim TS, Shisler J, Horton TM et al. Characterization of mutants within the gene for the adenovirus E3 q4.7-kilodalton protein which prevents cytolysis by tumor necrosis factor J Virol 1993 67: 2159–2167

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Hung W-C, Huang J-S, Chuang L-Y . Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression Biochem Biophys Res Commun 1996 220: 719–723

    Article  CAS  PubMed  Google Scholar 

  28. Schrump DS, Chen A, Consoli U . Inhibition of lung cancer proliferation by antisense cyclin D Cancer Gene Ther 1996 3: 131–135

    CAS  PubMed  Google Scholar 

  29. Kornmann M, Arber N, Korc M . Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum J Clin Invest 1998 101: 344–352

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Driscoll B, Wu L, Buckley S et al. Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth Am J Physiol 1997 273: L941–L949

    CAS  PubMed  Google Scholar 

  31. Arber N, Doki Y, Han E-H et al. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells Cancer Res 1997 57: 1569–1574

    CAS  PubMed  Google Scholar 

  32. Li Z, Rakkar A, Katayose Y et al. Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model Gene Ther 1998 5: 605–613

    Article  CAS  PubMed  Google Scholar 

  33. Powell SN, DeFrank JS, Connell P et al. Differential sensitivity of p53(−) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay Cancer Res 1995 55: 1643–1648

    CAS  PubMed  Google Scholar 

  34. St John LS, Sauter ER, Herlyn M et al. Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53 Cancer Gene Ther 2000 7: 749–756

    Article  CAS  PubMed  Google Scholar 

  35. Putzer BM, Bramson JL, Addison CL et al. Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer Hum Gene Ther 1998 9: 707–718

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Supported in part by National Institutes of Health Grants DE-00380 and CA-25874.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edward R Sauter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sauter, E., Takemoto, R., Litwin, S. et al. p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma. Cancer Gene Ther 9, 807–812 (2002). https://doi.org/10.1038/sj.cgt.7700492

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.cgt.7700492

Keywords

This article is cited by

Search

Quick links